FDA Inspection
Pyxant LabsPyxant Labs – FDA Inspection, Jul 20, 2017
Record Details
This FDA Inspection record concerns Pyxant Labs, with an inspection on July 20, 2017, issued by the Denver District Office, covering human drugs.
- Office
- Denver District Office
- People
- Srinivas Chennamaneni (Issuing Officer)
- Stephen T. Hansen (Company Rep)
View Company Profile
ID · dcf98026-84b6-4d99-905d-5d3062650237
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1018561
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 58.130(a)Conduct: in accordance with protocol
- 21 CFR 58.81(b)SOPs: required
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.